BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (NOVEMBER DECEMBER 2019)

Pharmaceutical Global Supply Chain - Risk Assessment and Strategy

Goutam Dutta1 & Kaushik Desai2

Introduction: Supply of medicine as a strategic product in healthcare is a top priority. Pharmaceutical companies, major players of the drug supply chain, are subjected to many risks. These risks interrupt the supply of medicines in many ways such as their quantity, quality, safety and their delivery to the right place, right customers and the right time. Therefore, risk identification and mitigation in the supply process of pharmaceutical companies are highly recommended. Most risks in pharmaceutical supply chain are internal risks due to the processes, people, technology, and functions mismanagement, which could be organised by suitable mitigation strategies.

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.